RLYB
Rallybio Corp
16.80$
-2.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | +0.0% | -87.3% | +457.9% | +0.0% | +0.0% | +4.7% | -4.5% | -100.0% | – | |
| – | -2.7% | -2.8% | -2.9% | +24,135.3% | -99.6% | +18,983.3% | +6.1% | -31.8% | -11.8% | -99.9% | – | – | |
| – | – | – | – | -3,096.6% | – | -69,012.5% | – | – | – | – | – | – | |
| – | +19.6% | -18.8% | +0.1% | -36.2% | -10.7% | -22.2% | +6.1% | -31.8% | -11.8% | -98.1% | +1,014.7% | – | |
| – | -14.6% | +32.1% | -36.0% | -6.0% | +3.3% | -2.4% | +0.9% | -28.6% | -0.5% | +103.9% | -19.4% | – | |
| – | +8.8% | -6.3% | -12.4% | -76.2% | +181.6% | -64.2% | +0.9% | -28.6% | -0.5% | +65.9% | +14.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -136.5% | – | – | – | |
| – | – | +11.7% | -28.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -136.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.